We're trying something different this week: a full post-show breakdown of every episode in the latest season of Black Mirror! Ari Romero is joined by Tudum's Black Mirror expert, Keisha Hatchett, to give you all the nuance, the insider commentary, and the details you might have missed in this incredible new season. Plus commentary from creator & showrunner Charlie Brooker! SPOILER ALERT: We're talking about the new season in detail and revealing key plot points. If you haven't watched yet, and you don't want to know what happens, turn back now! You can watch all seven seasons of Black Mirror now in your personalized virtual theater . Follow Netflix Podcasts and read more about Black Mirror on Tudum.com .…
Player FM - Internet Radio Done Right
Checked 5d ago
Додано forty-four тижнів тому
Вміст надано Executive Platforms. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Executive Platforms або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !
Переходьте в офлайн за допомогою програми Player FM !
))
Daily Deals
How Technology Fits into the Larger Conversation of Change in the Manufacturing Sector — A Conversation with Sathish Thirmoorthy of UCBOS
Manage episode 450871864 series 3580470
Вміст надано Executive Platforms. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Executive Platforms або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
At the 2024 edition of the North American Food Manufacturing Summit series we sat down with Sathish Thirmoorthy, the Chief Strategy Officer of UCBOS, to put into context how the new generation of technologies available to manufacturers are shaping how organizations function and evolve, especially in the current age of disruption. Far too often we focus on the incredible new capabilities unlocked by emerging tools, but it is important to remember that technology in the manufacturing space at its heart is about helping people do more with less, do things faster, and do things right the first time every time. How should Manufacturers combine their successes across different processes into one platform that coordinates, communicates, and consolidates these disparate systems into a larger whole to help the business move forward? What does that look like in real terms, and how can manufacturers take the fear factor out of embracing further change? For all this and more, give this episode a listen!
--
Sathish Thirumoorthy
Chief Strategy Officer
UCBOS Inc.
Sathish Kumar Thirumoorthy has an extensive background in enterprise services, supply chain consulting, and IT consulting. With experience in companies such as ITOrizon Inc., Oracle, CGI, and Hewlett Packard Enterprise, Sathish has held roles ranging from Senior Support Consultant to Director, Consulting and Practice Leader. Sathish’s expertise focuses on consulting, solutioning, presales pursuits, and client relationship management across various industry verticals. Sathish's career has been marked by strategic leadership, solution-based project delivery, and proactive proposal development to drive business growth and enable transformation for global clients.
--
UCBOS Inc.
Pioneering Zero Code Transformation
UCBOS, Inc. (“You See Boss”) is a visionary Zero Code software company based in the USA, committed to revolutionizing digital transformation for enterprises. UCBOS unique approach starts and ends with zero – zero data models, zero code, and most importantly, zero tech debt.
UCBOS offers an AI-enabled, zero-code business execution platform that integrates, optimizes, and orchestrates digital processes. Built on 100% No-Code, 100% Metadata, and 100% NoSQL technologies, UCBOS ensures seamless digital integration and a future-ready foundation for enterprise success.
266 епізодів
ПоширитиManage episode 450871864 series 3580470
Вміст надано Executive Platforms. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Executive Platforms або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
At the 2024 edition of the North American Food Manufacturing Summit series we sat down with Sathish Thirmoorthy, the Chief Strategy Officer of UCBOS, to put into context how the new generation of technologies available to manufacturers are shaping how organizations function and evolve, especially in the current age of disruption. Far too often we focus on the incredible new capabilities unlocked by emerging tools, but it is important to remember that technology in the manufacturing space at its heart is about helping people do more with less, do things faster, and do things right the first time every time. How should Manufacturers combine their successes across different processes into one platform that coordinates, communicates, and consolidates these disparate systems into a larger whole to help the business move forward? What does that look like in real terms, and how can manufacturers take the fear factor out of embracing further change? For all this and more, give this episode a listen!
--
Sathish Thirumoorthy
Chief Strategy Officer
UCBOS Inc.
Sathish Kumar Thirumoorthy has an extensive background in enterprise services, supply chain consulting, and IT consulting. With experience in companies such as ITOrizon Inc., Oracle, CGI, and Hewlett Packard Enterprise, Sathish has held roles ranging from Senior Support Consultant to Director, Consulting and Practice Leader. Sathish’s expertise focuses on consulting, solutioning, presales pursuits, and client relationship management across various industry verticals. Sathish's career has been marked by strategic leadership, solution-based project delivery, and proactive proposal development to drive business growth and enable transformation for global clients.
--
UCBOS Inc.
Pioneering Zero Code Transformation
UCBOS, Inc. (“You See Boss”) is a visionary Zero Code software company based in the USA, committed to revolutionizing digital transformation for enterprises. UCBOS unique approach starts and ends with zero – zero data models, zero code, and most importantly, zero tech debt.
UCBOS offers an AI-enabled, zero-code business execution platform that integrates, optimizes, and orchestrates digital processes. Built on 100% No-Code, 100% Metadata, and 100% NoSQL technologies, UCBOS ensures seamless digital integration and a future-ready foundation for enterprise success.
266 епізодів
Alle Folgen
×
T
The bluEPrint by Executive Platforms
1 A Speaker Roundtable from NAFES25 - A Finance Conversation with Volkswagen, Bayer US, and Alfasigma 50:58
At the 2025 edition of the North American Finance Executive Summit series we sat down with Elmar Licharz of Volkswagen, Guru Ramamurthy of Bayer US, and Tatiana Simonelli of Alfasigma —all members of the NAFES25 speaker faculty— for a wide-ranging discussion about the issues, ideas, challenges, and opportunities that are top of mind for finance leaders today, as suggested by the attendees of the event. Give it a listen! This roundtable includes… Panelists: Elmar Licharz Chief Financial Officer, North America Volkswagen Dr. Elmar-Marius Licharz, Chief Financial Officer for Volkswagen North American Region and Volkswagen Group of America, oversees the development and implementation of the financial strategy for Volkswagen Group of America. Elmar joined Volkswagen AG in Wolfsburg, Germany, in 2005, and most recently served in the position of Head of Digital Finance. Prior to joining Volkswagen AG, Elmar worked for McKinsey & Company, Inc. where he was responsible for national and international projects in the pharmaceutical, aerospace and automotive industries. Elmar earned his PhD at the University of Kassel. Guru Ramamurthy Chief Financial Officer, Bayer U.S. Bayer US Guru brings wide-ranging global finance and leadership experience across different businesses and countries. He has a strong track record of enabling business turnaround and expansion and driving functional transformation. Guru has worked with Bayer in a range of roles over the past 20 years. He recently served as Chief Financial Officer of AskBio from March 2021 to July 2023. He was previously the Global Finance Lead for the Oncology franchise from January 2020 until February 2021; CFO of the North American business at Bayer Consumer Health from 2016 to 2019; and CFO of the Bayer Medical Care Division from 2013 to 2016. Prior to that, he held various finance roles in Germany (Berlin, Wuppertal); Italy; Japan; and Berkeley, California. Before Bayer, his career was focused on finance, audit, and accounting roles at various companies, including Siemens, Citibank, and PWC. Guru holds an Executive Master of Business Administration degree from INSEAD, France, and a bachelor’s degree in commerce with emphasis in accounting and tax from St. Xavier’s College, India. He is an Associate Chartered Accountant (ACA) and Graduate Cost and Works Accountant (Grad CWA), both internationally recognized professional accounting degrees. Tatiana Simonelli Corporate CFO Alfasigma Tatiana is a transformative international business and finance leader with significant experience in tackling today’s complex challenges. Over nearly 30 years of global experience, she has acquired expertise in financial strategy, business model transformation, commercialization excellence, crisis navigation, and large-scale M&A integration. Tatiana is currently Corporate CFO in Alfasigma, Italian multinational pharma company with very ambitious organic and inorganic growth plans. Prior to that, she built her career in Bristol-Myers Squibb (BMS) over 15 years starting as Finance Director in Italy, then progressing in various senior roles in Commercial Finance, Business Development and Business Insights & Analytics; her last role in BMS was Senior Vice President of Finance for Commercialization providing financial leadership to ~45+$Bln business. Before joining BMS, Tatiana spent 14 years in Finance leadership roles at Procter & Gamble in Russia and Italy. Moderator: Geoff Micks Head of Content & Research Executive Platforms…
T
The bluEPrint by Executive Platforms
1 Asking the Right Questions About EPM Systems - A Conversation with Rob Konferowicz of CCH Tagetik 20:15
At the 2025 edition of the North American Finance Executive Summit series we sat down with Rob Konferowicz of CCH Tagetik. A new generation of Enterprise Performance Management tools is coming online. As the older tools become less and less suited to a changing business landscape, many finance professionals are being asked to make informed choices in relatively short time frames about the technologies they will be using for many years to come. Should contracts be renewed for the next edition of the tried, tested, and true? What are the other options out there, and how do they compare? How should these executives gather the information they need to identify the best solutions to their organizations’ specific challenges and opportunities? What do they need to know, and what is the best way to get impactful, meaningful answers? For all this and more, give this episode a listen! -- Rob Konferowicz Director of Operations CCH Tagetik Rob Konferowicz is CCH Tagetik’s leading expert on Corporate Performance Management solutions and helps large enterprise companies make appropriate, long-term strategic decisions on CPM solutions during their software evaluation cycles. Rob translates customer requirements and industry challenges into best practices with CCH Tagetik. -- Wolters Kluwer | CCH Tagetik The award-winning CCH Tagetik expert solution provides the strategic & financial intelligence platform that enables CFOs and their peers, in global enterprises, to propel their strategy with faster and better-informed decisions. CCH Tagetik provides a comprehensive, data-driven, AI-based CPM platform for Financial Close & Consolidation, Extended Planning including financial & operational planning, ESG and Regulatory reporting, and Corporate Tax including Global Minimum Tax. With embedded AI and state-of-the-art governance, the open and extensible platform easily connects leading operational solutions to create enterprise-wide insights, drive growth, and navigate change for our customers to gain the greatest value, today and tomorrow.…
T
The bluEPrint by Executive Platforms
1 A Speaker Roundtable from NAFES25 - A Finance Conversation Among Senior Executives on the Issues and Ideas that Matter Most 25:58
For this special episode of Executive Platforms' BluEPrint Podcast series we had some of the top speakers from the 2025 edition of the North American Finance Executive Summit series sit down and speak to the challenges and opportunities submitted by attendees of the event as they filled out their delegate profiles, weighted by popularity. This wide-ranging conversation will see four senior executives from four very different companies speaking to the issues, ideas, innovations, and inspirations that matter to all of them as prompted by their peers. It is a fantastic deep dive into what is most relevant to finance leaders today. Give it a listen! This roundtable includes… Panelists: Jennifer Cloherty Chief Financial Officer Dawn Foods Global Jennifer Cloherty is Dawn’s Chief Financial Officer and member of the Dawn Leadership Team. In her role at Dawn, Jennifer is responsible for all financial and M&A activities of the multi-billion-dollar global enterprise. Jennifer has 29 years of global business experience in roles of increasing responsibility, complexity, and scale. Prior to joining Dawn, Jennifer spent 4 years as the CFO for Kellogg North America and has also been a segment CFO for the largest reporting segments of Aptiv and Owens Corning. She spent the first 20 years of her career with GE in numerous operational and commercial finance roles across both the United States and Europe. Wetteny Joseph Executive Vice President & Chief Financial Officer Zoetis Wetteny Joseph is executive vice president and Chief Financial Officer of Zoetis, the world’s leading animal health company and a member of the Fortune 500. In this role, he is responsible for overseeing the financial management, planning, operations and indirect procurement functions. Mr. Joseph also has oversight responsibility for the company’s Human Health Diagnostics business. Mr. Joseph joined Zoetis in June 2021, after having spent 13 years in executive positions at Catalent, a global leader in pharmaceuticals, biologics and consumer health products. Daya Harvey Executive Director, Enabling Functions Finance & Finance Innovation CSL Behring Daya is the leader of the Enabling Functions Finance & Finance Innovation teams at CSL, a global biotech company. With over 20 years of experience across the US, Australia and Europe, and a passion for continuous improvement and innovation, my track record includes driving strategic projects. delivering financial excellence and value-added solutions. She combines deep financial knowledge with a strategic mindset to provide actionable insights, drive informed decision-making, and offer strategic advice to executive leadership. Heather Clayton Chief Financial Officer Vegas Golden Knights Heather Clayton is Chief Financial Officer for the Vegas Golden Knights and has worked in three positions within the Company over the past 5 years. Prior to her current position, Clayton held the Vice President of Finance and Accounting and Controller roles for the Company and assisted in the growth of the accounting and finance department jumping from two entities to the current thirteen entities in just over two years. Clayton oversees the financial accounts of all Knight- related venues and five partnering foundations and assisted with numerous hotel acquisitions. Prior to joining The Vegas Golden Knights, Clayton gained experience from a handful of other well-respected roles within the casino industry and educated herself to challenging levels. Moderator: Geoff Micks Head of Content & Research Executive Platforms…
T
The bluEPrint by Executive Platforms
1 Doing More with Less: The Challenges Non-Profits Face and Address Utilizing Best Practices — A Conversation with Mandy Jacomet of NeighborWorks Toledo Region 27:55
At the 2025 edition of the North American Finance Executive Summit series we sat down with Mandy Jacomet, the Chief Financial Officer of NeighborWorks Toledo Region to talk about her experience bringing lessons learned and best practices she had gained through work in the private sector and applying them to a non-profit organization without always having the resources a finance leader may have had in a for-profit environment. How do you achieve everything you need to achieve within necessary constraints? How do you make sure the most value possible is being put into the end result, and how do you document it, and how do you improve that performance even further over time? What can other non-profit organizations take from NeighborWorks Toledo’s experience? For all this and more, give this episode a listen! -- Mandy Jacomet Chief Financial Officer NeighborWorks Toledo Region Mandy is the Chief Financial Officer for NeighborWorks Toledo Region located in Northwest, Ohio. NeighborWorks Toledo Region is a chartered member of NeighborWorks America focusing on community development initiatives by providing financial education, promoting homeownership, developing affordable housing, and performing Weatherization services for those who qualify in order to reduce energy costs, promote self-sufficiency, and improve the lives of individuals in our communities. Mandy has 25+ years of financial and managerial accounting experience in a variety of industries including manufacturing, construction, information technology, higher education and client services. She holds her MBA in Organizational Leadership and Development from Tiffin University and a Bachelor’s in Financial Accounting from the University of Findlay. Additionally, she is a licensed Mortgage Lending Officer and a HUD Certified Housing Counselor.…
T
The bluEPrint by Executive Platforms
In the run-up to the 2025 edition of the North American Sustainability & Responsibility Summit series we spoke with Jessica Monserrate and Jordan Keller of BASF, a 150-year-old chemical company with 111,000 employees working in 230 production and R&D sites in 90 countries. BASF is committed to ambitious sustainability targets, including a 25% reduction in Scope 1 and 2 greenhouse gas emissions by 2030 and achieving net zero across all scopes by 2050. In this wide-ranging conversation, we explore how BASF is driving sustainability, which role renewable carbon plays, the importance of mass balance and agriculture, and how all of these efforts can provide significant benefits to both customers and the environment. For all this and more, give this episode a listen! -- Jessica Monserrate Head of Sustainability Agricultural Solutions, NA BASF Jessica has 10 years’ experience in R&D, most recently serving as Head of Microbiome Discovery and Head of Trait Engineering driving new lead discovery and improvement for Trait Research in Pest, Herbicide and Disease Control. During this time, she led the operation to manage and screen BASF’s 100,000 microbial strain collection looking for input traits and natural product chemistries for a variety of research projects. Prior to this she led the Mode of Action team for Bater as well as several global projects related to scouting for new bio-based solutions for pest control, and worked with VC fluids for the creation of new start-ups. Jessica earned her Doctorate in Genetics, Cell Biology and Biochemistry from the University of California, Irvine followed by a post doctorate at Duke University studying small molecule and protein interactions. Her passion is to apply scientific innovation in solving the world’s greatest challenges and proudly represents BASF’s commitment to sustainability. Jordan Keller Head of Renewable Carbon NA BASF Renewable Carbon (BReC) Jordan Keller joined BASF twelve years ago as an engineer and has held roles of growing responsibility ever since. Today she is the Head of Renewable Carbon for North America, after more than two years as the Senior Manager Biomass Balance Solutions North America. Jordan graduated from the University of Texas in 2013 with a degree in chemical engineering and now works for BASF in Houston. -- BASF is a global chemical company that combines economic success with environmental protection and social responsibility. The company has around 112,000 employees in more than 90 countries, managing over 230 production sites, including 6 Verbund sites. In the United States, BASF runs over 100 production and research and development (R&D) facilities. The company boasts a diverse portfolio of more than 45,000 products for the segments Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural SolutionsIn 2023, BASF reported a turnover of 68.9 billion euros. BASF is committed to ambitious sustainability targets, including a 25% reduction in Scope 1 and 2 greenhouse gas emissions by 2030 and achieving net zero across all scopes by 2050. In terms of the circular economy, BASF is committed to decoupling growth from resource consumption. The company aims to generate sales of € 10 billion from Loop Solutions for our customers by 2030 (2023: €5 billion). This encompasses revenue from circular products, which are based on renewable or recycled materials or support the recycling process (close the loop), as well as products that increase the durability or prolong the lifespan of materials (extend the loop).…
T
The bluEPrint by Executive Platforms
1 How Medical Device Companies and CDMOs are Partnering Together to Drive Innovation and Serve Patients Better 21:12
In the run-up to the 2025 edition of the Medical Device Manufacturing Excellence Summit series we spoke with Shawn McCarthy, Jessica Swanson, and Peggy Hansen of Regenity Biosciences about exciting developments in the Medical Device space, with a particular emphasis on both the power of collaboration and the importance of a regulatory strategy. Regenity is an industry-leading CDMO working with 120 different industry partners and offering special expertise in regenerative devices. In this wide-ranging conversation we talk about industry trends, how medical device manufacturers are evolving to continue to meet the needs of patients, and also about some of the big ideas Regenity wants to share with the executives attending MDMES25. For all this and more, give this episode a listen! -- Regenity Biosciences, a Linden Capital Partners portfolio company, is a leading global developer and manufacturer of bioresorbable technologies to repair and regenerate natural tissue and bone for a variety of markets including dental, spine, orthopedic, sports medicine, advanced wound, neurosurgery, ENT, and nerve repair. Founded in 1997, Regenity (formerly Collagen Matrix, Inc.) is headquartered in Paramus, New Jersey, with manufacturing locations in Oakland and Allendale, New Jersey and Groningen, the Netherlands. Regenity’s product portfolio includes a variety of collagen-based and synthetic polymer solutions that support the company’s platform for tissue and bone regeneration. Regenity develops proprietary products that are sold to OEM customers on either a contract or private label basis and offers partnership opportunities including contract product development and manufacturing services. For more information, please visit www.regenity.com .…
T
The bluEPrint by Executive Platforms
There is a podcast Executive Platforms would like to bring to the attention of our network of senior executives. For everyone interested in online speech, especially issues like trust and safety, content moderation, regulations and compliance, and how technology is changing the way people engage with one another, we recommend the Ctrl-Alt-Speech Podcast co-hosted by Techdirt’s Mike Masnick and Everything in Moderation’s Ben Whitelaw. In this episode we talk about how the podcast came to be, what it hopes to do to help people navigate the evolving landscape of online speech, and what business leaders especially should be thinking about and learning about to prepare their organizations for a new and changing reality, with all that means for the future of commerce. For all this and more, give this episode a listen! Mike Masnick Co-Host, Ctrl-Alt-Speech Podcast CEO and Founder, Techdirt Ben Whitelaw Co-Host, Ctrl-Alt-Speech Podcast Editor, Everything in Moderation…
T
The bluEPrint by Executive Platforms
1 Where Cell and Gene Therapies are Going — A Conversation with Diluks De Silva of Compliance Architects 14:47
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Diluks de Silva to talk about Cell and Gene Therapies. For many years we have been hearing these and other Advanced Therapy Medicinal Products (ATMPs) are moving towards commercialization, and each individual therapy that has been approved is heralded as a pioneer to be celebrated and studied for lessons learned and best practices. This year something like 40 cell and gene therapies came to market, and by every indication this is just the start of a whole new generation of medicine about to help patients around the world. What does that look like on the ground? What is the industry doing to prepare itself for what comes next? How do you control things like cost and scalability while you are still inventing how to manufacture the new therapies in the first place? How are these innovations pairing with medical devices, and what does that mean for the future of medicine? There is so much good work being done, and so much still to do. As always, the experts at Compliance Architects have a comprehensive understanding of where the industry is, where it is going, and what needs to happen to ensure everyone’s success. For everyone looking for the updates that matter most on this exciting frontier of medicine, give this episode a listen! -- Diluks De Silva Vice President Compliance Architects LLC -- Compliance Architects LLC Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes. Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.…
T
The bluEPrint by Executive Platforms
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Hari Pujar of Tessera Therapeutics and Flagship Pioneering to offer a concise but still in-depth look at the present and future of biopharmaceutical manufacturing, especially as it relates to Advanced Therapy Medicinal Products (ATMPs). Incredible progress has been made and is being made, but of course there are bottlenecks to be addressed as the industry grows, and as these new treatments become commercially available, the issue of cost comes into sharp focus. Where does the industry find itself today, and what are its plans for tomorrow? Give this interview a listen for a terrific window into the state of an industry on the cusp of an incredibly bright future. -- Hari Pujar Chief Operating Officer & Operating Partner Tessera Therapeutics & Flagship Pioneering Hari is a biopharmaceutical executive with experience in vaccine, biologics, mRNA, small molecule, gene therapy modalities, with a passion for value creation. He has enterprise-wide experience including platform and product development, cGMP manufacturing, and commercial, with geographies spanning North and South America, Europe, and Asia.…
T
The bluEPrint by Executive Platforms
1 Martin Müller & Søren Thuesen Pedersen of Novo Nordisk — Collaboration Among Industry Peers to Move the Life Sciences Forward 24:05
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Martin Müller and Søren Thuesen Pedersen of Novo Nordisk to talk about opportunities biopharmaceutical manufacturers have to work together to lower costs, standardize equipment, build win-win scenarios for procurement and supply chain, and similar initiatives where competitive advantage and IP are not at stake, but costs and compliance and other performance metrics can be improved through joining forces and agreeing on things collectively rather than each company having to reinvent its own wheel on every issue. Building upon their earlier presentation that covered much of the same content, we discuss what would that collaboration look like in real terms? What does getting started look like, and how can interested companies join the ongoing conversations and deliberations? For all that and more, give this episode a listen! -- Martin Müller Director Technology Development - AMSAT - Technology Innovation Novo Nordisk Martin P. Müller joined Novo Nordisk in 2014 and currently directs development projects for innovative technologies within Aseptic Manufacturing, with particular focus on formulation, filling, wash & sterilization, and environmental monitoring. Before moving to production in Novo Nordisk, Mr. Müller has served 10 years in Device R&D, driving the digital agenda of the area, external affairs and QMS-processes and project management, among others. Mr. Müller earned his Master of Arts from Humboldt University Berlin, Germany, and his Master of Business Administration from Copenhagen Business School, Denmark. Søren Thuesen Pedersen Senior Director, External Affairs Regulatory Policy and Intelligence Novo Nordisk Søren Thuesen Pedersen is Senior Director, External Affairs, Regulatory Policy and Intelligence at Novo Nordisk. He is a Chemical Engineer by education and has been working 30 years in Novo Nordisk. During that that time he has been engaged and lead different areas within Manufacturing, QC-Laboratory and CMC Manufacturing Development. He has been one of the founding fathers of the Novo Nordisk External Requirements’ Process; How does Novo Nordisk ensure compliance of new external requirements? Mr. Pedersen is currently responsible for the External Representation and Advocacy strategy out of Novo Nordisk’s GMP&Q area and represents Novo Nordisk in various associations ISPE, EFPIA, IFPMA and BIO. Specifically, Mr. Pedersen is a member of the EFPIA Manufacturing Quality Expert Group (MQEG) since 2019 and member of the Board of Directors in IQ Consortium. He has furthermore been member of the Novo Nordisk Board of Directors for 12 years as an elected employee representative. His spare time interests include Danish and EU Politics.…
T
The bluEPrint by Executive Platforms
1 The Speaker Roundtable from BMWS24 — A Conversation About Biopharmaceutical Manufacturing Issues and Ideas 1:05:55
1:05:55 
Відтворити Пізніше 
Відтворити Пізніше 
Списки 
Подобається 
Подобається1:05:55
Відтворити Пізніше Відтворити Пізніше Списки Подобається ПодобаєтьсяFor this special episode of Executive Platforms' bluEPrint Podcast series we had some of the most senior speakers and delegates from the 2024 edition of the long-running Biomanufacturing World Summit series sit down and speak to the challenges and opportunities submitted by attendees of the event as they filled out their delegate profiles, weighted by popularity. With topics ranging from leadership and culture, to talent attraction, development and retention, to supply chain issues, to commercializing CGTs and other ATMPs, change and disruption throughout the business landscape, and how to serve patients better now and in the future, this wide-ranging conversation sees five senior executives from five very different companies speaking to the issues, ideas, innovations, and inspirations that matter to all of them as guided by a moderator who knows the industry inside and out. It is a fantastic deep dive into what is most relevant to biopharma technical operations leaders today. Give it a listen! Our roundtable panelists are… Moderator: Pascal Bécotte Managing Director Russell Reynolds Panelists: J erry Murry Senior Vice President, Process Development Amgen Tongtong Wang Senior Vice President, Global Head Technical Development Roche Chris Horan Chief Technical Operations Officer Artiva Biotherapeutics Aine Hanly CTO Vir Biotechnology Tina Self Senior Vice President, Global Biologics Manufacturing & Berkeley Site Head Bayer…
T
The bluEPrint by Executive Platforms
1 AI in Supply Chains: Today's Real-World Applications and What is Still to Come — A Conversation with Experts from Ernst & Young LLP 18:46
At the 2024 edition of the North American Supply Chain Executive Summit series we sat down with two of Ernst & Young LLP’s supply chain leaders to talk about how AI is shaping supply chain operations today, what we can look forward to in the near future, and also where our current use cases are tempering some of the more hyperbolic expectations while also illustrating real-world capabilities that are going to change the way businesses approach data-intensive tasks throughout their value chain and S&OP processes. Takshay Aggarwal and Parag Jategaonkar have more than 45 years of experience between them helping companies bring new technologies into their existing systems and processes, and their enthusiasm for where AI can transform supply chains is palpable. To hear what they have to say, give this episode a listen! -- Takshay Aggarwal EY Americas Supply Chain Growth Platforms Leader Ernst & Young LLP Takshay leads Supply Chain Growth Platforms and Alliances for the EY Americas Supply Chain and Operations practice. Takshay brings over 20 years of end-to-end supply chain experience in consumer products, retail, automotive, industrial and life sciences. He’s helped companies transform their operating models to provide better customer experiences and improve their productivity by leveraging technology and artificial intelligence capabilities using cloud and platform approaches. Takshay helps clients gain a competitive advantage via digital and analytics while becoming more agile. Parag Jategaonkar US End to End Supply Chain Strategy and Transformation Leader Ernst & Young LLP Parag is an innovative, people-oriented leader with over 25 years of management consulting experience helping clients improve business performance and achieve their goals. -- Ernst & Young LLP In Consulting, we are building a better working world by transforming businesses through the power of people, technology and innovation. The diversity and skills of 70,000+ people will help clients realize transformation by putting humans at the center, delivering technology at speed and leveraging innovation at scale. www.ey.com/en_gl…
T
The bluEPrint by Executive Platforms
1 How CDMOs are Contributing to the Ongoing Future of Medicine — A Conversation with Nick Maragos of Northway Biotech 11:57
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Nick Maragos of Northway Biotech to talk about how biopharmaceutical manufacturers are increasingly partnering with CDMOs to advance the future of medicine, how that working relationship is evolving over time, and what CDMOs need to do to continue to grow and meet the needs of the industry. With special reference to Northway Biotech’s own example, Nick talks about how companies can ensure they are compatible, what the working relationship needs to be, and what factors need to be included in any informed decision-making before and during a partnership. Give this episode a listen! -- Nick Maragos VP Business Development Northway Biotech -- Northway Biotech Northway Biotech is an end-to-end biologics contract development and manufacturing organization (CDMO) supporting customers worldwide. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and located in Vilnius, Lithuania and Waltham, Mass., U.S.…
T
The bluEPrint by Executive Platforms
1 ‘First in Human’ Continuous Manufacturing in Biopharmaceuticals — A Conversation with Magnus Schroeder of Just – Evotec Biologics 10:52
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Magnus Schroeder, the VP, Process & Product Design for Just – Evotec Biologics, to talk about some of the advantages of continuous manufacturing in biopharmaceutical manufacturing, especially for companies whose products are approaching the First in Human (FIH) stage. It is never too early to think about process optimization, scalability, and controlling costs, but there is an understandable position where companies focused on the medicine and the science believe that can be sorted out later. Just – Evotec Biologics is a passionate advocate for taking lessons from other industries that build their businesses’ success into the R&D stage of their products’ development. So what does that look like in the Life Sciences? What role do CDMOs need to play to help the industry succeed at this, especially at the crucial FIH stage? For all this and more, give this episode a listen! -- Magnus Schroeder VP, Process & Product Design Just – Evotec Biologics -- Just – Evotec Biologics , wholly owned by Evotec SE, is a CDMO offering development and manufacturing services for antibody, next-generation biologics, and biosimilar products. We collaborate with partners starting from antibody discovery through process development and manufacturing with sites in US and Europe. We designed our technologies to reduce cost of goods and help expand global access to affordable high-quality biotherapeutics. Our team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics.…
T
The bluEPrint by Executive Platforms
1 John H. Adams, Jr. of Spark Therapeutics — Computer Software Assurance for Biopharmaceutical Manufacturers 14:33
At the 2024 edition of the Biomanufacturing World Summit series we sat down with John H. Adams, Jr., Spark Therapeutics’ Senior Director, Validation, to talk about Computer Software Assurance in the Life Sciences. John has been doing Computer Systems Validation (CSV) for decades as a regulatory requirement, so when talk of a risk-based Computer Software Assurance (CSA) requirement started making the rounds, he was interested to understand the differences so he could best stay ahead of the compliance curve and ensure his best practices were not out of step with expectations. In this episode, John walks us through where the conversation between industry and regulators currently stands, what validation professionals should already be doing, what they should continue to do, what they should confirm they are doing correctly, and what they should prepare themselves for if and when current guidance becomes new regulations. For everyone in the Life Sciences who cares about the compliance of manufacturing systems, give this episode a listen! -- John H. Adams, Jr. Senior Director, Validation Spark Therapeutics In his current role as the Senior Director of Validation at Spark, John leverages over 24 years of expertise in the compliance and validation of enterprise computer systems, applications, and equipment regulated by the FDA and EU. John is a compliance and validation thought leader and has a deep understanding of 21 CFR Parts 210, 211, 606, 820, 11, and Annex 11. John’s experience spans a variety of analytical systems, including HPLCs and spectrophotometers, as well as computer systems such as ERP, LIMS, EDMS, EMS, PCS, and DCS, serving major pharmaceutical, medical device, and blood management companies. Before joining Spark in May of 2015, his career included roles at Pfizer, AstraZeneca, TEVA, Smith & Nephew, GE Healthcare, DSM, Haemonetics, and the American Red Cross, where he has consistently ensured compliance with predicate rules, 21 CFR Part 11, and GAMP 5 guidance. John holds a Bachelor of Science degree in Computer Information Systems from the Florida Institute of Technology.…
Ласкаво просимо до Player FM!
Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.
Daily Deals
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !
Переходьте в офлайн за допомогою програми Player FM !
))
